May 2016

This review examines the breadth of published work on interventions addressing nonmedical determinants of health that are supported by Medicaid managed care organizations.

Hybrid approaches allow for clinician input into case finding for care management, but training and monitoring is required to protect against unintentional biases.

The authors surveyed physicians regarding “Choosing Wisely” and hypothesized drivers of overuse, finding high reported prevalence of hypothesized drivers of overuse and widespread support for cost-consciousness.

Biosimilars in the United States may demonstrate higher discounts and cost reduction than current estimates.

A multigene test for breast cancer recurrence risk was used in a minority of eligible patients, yet was associated with a decrease in chemotherapy use.

The authors used the modified Delphi method to develop local orthopedic referral guidelines, enabling detailed decision support and non—face-to-face consultation at the point of referral.

This study examines the relationship between Medicaid managed care penetration within a state and spending on pharmaceuticals for patients with serious mental illnesses.

This paper estimates the costs and benefits of over-the-counter (OTC) statins using data on statin use and cardiovascular risk, clinical studies of statin safety and efficacy, and an OTC statin use trial.

In a statewide telephone survey, patient-reported indicators of the patient-centered medical home correlated with improved process measures in diabetes, cholesterol screening, vaccination, and care access.

The authors evaluated the clinical applicability, accuracy, and implications of using an automated risk calculator and risk-based decision tool in an integrated health system.